Home/Filings/4/0001209191-21-033334
4//SEC Filing

Lin Celia 4

Accession 0001209191-21-033334

CIK 0001831828other

Filed

May 16, 8:00 PM ET

Accepted

May 17, 8:33 PM ET

Size

5.4 KB

Accession

0001209191-21-033334

Insider Transaction Report

Form 4
Period: 2021-05-13
Lin Celia
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-05-13+16,91616,916 total
    Exercise: $11.00Exp: 2031-05-12Class A Common Stock (16,916 underlying)
Footnotes (1)
  • [F1]1/4 of the shares subject to the option vest on May 13, 2022, and 1/48 of the shares vest monthly thereafter.

Issuer

Vera Therapeutics, Inc.

CIK 0001831828

Entity typeother

Related Parties

1
  • filerCIK 0001859386

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 8:33 PM ET
Size
5.4 KB